SPR-210
4-Hydroxy-2-hexenal BSA Conjugate
Cannot supply to this region.
- SKU:
- SPR-210
- Additional Names:
- 4-Hydroxy-2-hexenal (4-HHE) BSA Conjugate, 4-Hydroxy-2-hexenal BSA Conjugate, 4-HHE BSA Conjugate, 4-Hydroxy-2-hexenal-BSA Conjugate, 4-Hydroxy-2-hexenal (BSA) Conjugate, MG-BSA, MG-BSA Conjugate, MG-modified BSA, 4-Hydroxy-2-hexenal-modified BSA, 4-Hydroxy-2-hexenal Bovine Serum Albumin Conjugate, 4-Hydroxy-2-hexenal-Bovine Serum Albumin Conjugate, 4-Hydroxy-2-hexenal (Bovine Serum Albumin) Conjugate, MG-Bovine Serum Albumin, MG-Bovine Serum Albumin Conjugate, MG-modified Bovine Serum
- Application:
- ELISA, WB
- Purity:
- >98%
- Storage Conditions:
- -20[o]C
- Supplier:
- StressMarq Biosciences
- ABP:
- No Import Docs
- Buffer:
- PBS pH 7.4, 0.09% Sodium Azide
- Immunogen:
- 4-Hydroxy-2-hexenal BSA Conjugate
- Extra Details:
- 4-Hydroxy-2-hexenal (HHE) BSA Conjugate is a lipid peroxidation marker used to study oxidative damage in neural tissues. HHE is generated from the oxidation of omega-3 polyunsaturated fatty acids and forms covalent adducts with proteins, altering their structure and function. In the nervous system, HHE accumulation is associated with mitochondrial dysfunction, synaptic impairment, and neuroinflammation. Elevated HHE levels have been observed in neurodegenerative conditions such as Alzheimer's disease and ischemic brain injury, where they contribute to neuronal apoptosis and glial activation. The BSA-conjugated form allows for sensitive detection of HHE-modified proteins in immunoassays and histological studies. It supports research into the molecular mechanisms of oxidative stress and the development of antioxidant therapies targeting lipid peroxidation in neurodegeneration.
- Shipping Conditions:
- Blue Ice